An error occured. Details Hide
You have unsaved pages. Restore Cancel

Pfizer diluted eps

0.68 US dollars in 1st quarter 2019

Though pfizer diluted eps fluctuated substantially in recent years, it tended to increase through 2014 - 2019 period ending at 0.68 US dollars in 1st quarter 2019.

The description is composed by our digital data assistant.
Date Value Change, %
2019Q1 0.68 -1,233.33 %
2018Q4 -0.06 -108.70 %
2018Q3 0.69 6.15 %
2018Q2 0.65 10.17 %
2018Q1 0.59 -70.94 %
2017Q4 2.03 331.91 %
2017Q3 0.47 -7.84 %
2017Q2 0.51 0.00 %
2017Q1 0.51 264.29 %
2016Q4 0.14 -67.44 %
2016Q3 0.43 30.30 %
2016Q2 0.33
Basic EPS 0.69 US dollars in 1st quarter 2019 ADVFN
Cost of Sales with Depreciation 2,433 millions of US Dollars in 1st quarter 2019 ADVFN
Depreciation millions of US Dollars in 1st quarter 2019 ADVFN
DPS 0.36 US dollars in 1st quarter 2019 ADVFN
EBIT 4,684 millions of US Dollars in 1st quarter 2019 ADVFN
EBITDA 6,229 millions of US Dollars in 1st quarter 2019 ADVFN
Net Income 3,884 millions of US Dollars in 1st quarter 2019 ADVFN
Operating Income 4,460 millions of US Dollars in 1st quarter 2019 ADVFN
Operating Profit after Depreciation 6,229 millions of US Dollars in 1st quarter 2019 ADVFN
Pre-Tax Income 4,323 millions of US Dollars in 1st quarter 2019 ADVFN
Revenue 13,118 millions of US Dollars in 1st quarter 2019 ADVFN
Johnson & Johnson 1.39 US dollars in 1st quarter 2019 ADVFN

Our Privacy Statement & Cookie Policy

Our website uses cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your personal cookie settings through your internet browser settings.

Privacy Policy